Elamipretide: a drug to protect your eyes from AMD
Ophthalmology Times - 07-Jul-2021Elamipritide protects your retinal cells from undergoing degeneration
Join the club for FREE to access the whole archive and other member benefits.
Professor and Director of the Duke Center for Macular Diseases at Duke University
Scott W. Cousins, M.D. is currently the Robert Machemer, M.D. Professor of Ophthalmology and Immunology, Vice Chair for Research, and Director of the Duke Center for Macular Diseases at Duke Eye Center. Dr. Cousins is also Medical Director of Hospital-Based Imaging and Procedures for Duke Eye Center. He has served as a consultant or member of data safety monitoring committees (DSMC) for numerous pharmaceutical and biotechnology startup companies.
Dr. Cousins obtained B.A. from Dartmouth College in 1977 and M.D. from Case Western Reserve University in 1982.
Dr. Cousins is active in both clinical and laboratory research. In his clinical practice, Dr. Cousins is involved in many trials and innovative therapies for the treatment of macular diseases, especially AMD and diabetic retinopathy. He has served as site PI for numerous phase1-3 clinical trials in AMD, diabetic retinopathy, and other retinal disorders.
His laboratory is attempting to develop treatments for dry macular degeneration and improving vision in eyes with wet macular degeneration. His program is also developing blood tests and new imaging technologies for the identification of patients who are at high risk for progressing into complications.
Visit website: https://dukeeyecenter.duke.edu/about/faculty/scott-william-cousins-md
See also: Duke University School of Medicine - Top Medical School, Duke University
Details last updated 05-Sep-2021
Elamipritide protects your retinal cells from undergoing degeneration